SubHero Banner

Corlanor® (ivabradine) – New orphan indication, new formulation approval

April 22, 2019 - The FDA approved Amgen’s Corlanor (ivabradine) oral solution, for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate.

Download PDF